Category Archives: News

How Will Accountable Care Organizations Hit Drug Sales?

It’s not yet clear whether physicians will rush to form accountable care organizations (ACOs) in light of newly proposed Centers for Medicare and Medicaid Services (CMS) guidelines, which are lengthy, but pharmaceutical companies hoping to do business with ACOs will have to show that expensive brand drugs can offer not just better health outcomes, but [...]
Also posted in Legal, Regulatory, Sales, Strategy, healthcare | Tagged , , , , , | Leave a comment

New PwC Paper Looks Ahead into the Future of Pharma

Continuing cost pressures and new customer demands require a fresh look at existing roles of industry players. A new paper from PwC, entitled “Top Health Industry Issues of 2011,” foretells of change in the coming year due to health reform and other issues that are keeping the industry on its toes. “The new health reform law will [...]
Posted in News | Tagged | 2 Comments

Looking Into the Future: FDA’s 2011 Guidance Agenda

On December 7, FDA released its annual guidance agenda, which serves as a blueprint—almost a wish list— for what the organization plans to focus its time and resources on in the coming year. FDA’s good guidance practices regulations [GGP] require it to publish for public comment an annual summary of key priorities in the coming calendar [...]
Also posted in FDA | Tagged | Leave a comment

Federal Judge Declares Mandatory Health Insurance Unconstitutional

This new decision out of Virginia increases the prospect of a showdown between an elected Congress and President and the Supreme Court over the legality of this year’s health reform legislation affecting nearly one-fifth of the US economy. Resolution of the court case is unlikely before 2012—which is also an election year. Earlier this week, [...]
Also posted in Legal | Tagged , | 3 Comments

Workforce Shortage in Oncology Imminent

Supply and demand for oncology specialists is expected to become even more unbalanced in the US market over the next 10 years, particularly as the new health reform legislation creates more uncertainty for the reimbursement of the high cost biologic treatments now coming on stream. Several survey are documenting the shortage and suggesting that the [...]
Also posted in Agency Insight | Tagged | 2 Comments